Marshall Wace
KURA icon

Marshall Wace’s Kura Oncology KURA Stock Holding History

Marshall Wace’s Portfolio KURA Stock Details KURA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-488,753
Closed -$4.33M – 3224
2025
Q3 		$4.33M Buy
488,753
+446,390
+1,054% +$3.18M ﹤0.01% 1242
2025
Q2 		$244K Sell
42,363
-349,686
-89% -$2.14M ﹤0.01% 2392
2025
Q1 		$2.59M Sell
392,049
-556,856
-59% -$4.34M ﹤0.01% 1354
2024
Q4 		$8.26M Buy
+948,905
New +$13.7M 0.01% 865
2024
Q3 		– Sell
-26,267
Closed -$541K – 2757
2024
Q2 		$541K Buy
+26,267
New +$540K ﹤0.01% 1931
2023
Q3 		– Sell
-80,004
Closed -$846K – 2467
2023
Q2 		$846K Buy
+80,004
New +$946K ﹤0.01% 1787
2021
Q1 		– Sell
-111,936
Closed -$3.66M – 2687
2020
Q4 		$3.66M Buy
+111,936
New +$3.93M 0.02% 687
2020
Q3 		– Sell
-13,855
Closed -$225K – 1768
2020
Q2 		$225K Buy
+13,855
New +$200K ﹤0.01% 1390
2019
Q4 		– Sell
-38,184
Closed -$579K – 1905
2019
Q3 		$579K Sell
38,184
-309,514
-89% -$5.51M ﹤0.01% 1069
2019
Q2 		$6.85M Buy
347,698
+325,258
+1,449% +$5.4M 0.06% 390
2019
Q1 		$372K Buy
+22,440
New +$346K ﹤0.01% 1217
2018
Q2 		– Sell
-11,000
Closed -$206K – 769
2018
Q1 		$206K Buy
+11,000
New +$214K 0.01% 520

Other funds holding KURA

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.91B AUM 304.52% 1-Year Est. Return
SCM
Suvretta Capital Management New York $5.47B AUM 131.34% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
AC
Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
PM
Prosight Management Dallas, Texas $580M AUM 29.81% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Jacobs Levy Equity Management
Jacobs Levy Equity Management Florham Park, New Jersey $27.8B AUM 46.46% 1-Year Est. Return

Marshall Wace's KURA Position: Q4 2025 in Review

Marshall Wace sold out of Kura Oncology (KURA) in Q4 2025, closing a stake of 488,753 shares — an estimated $4.33M sold.

Marshall Wace first reported a position in KURA in Q1 2018 and held it in 12 quarters. The position peaked at $8.26M in Q4 2024. 215 funds tracked by Wall St. Rank hold KURA as of Q4 2025.

  • Marshall Wace reported no remaining Kura Oncology position as of Q4 2025 after selling out during the quarter.
  • Marshall Wace sold 488,753 Kura Oncology shares in Q4 2025, an estimated $4.33M.
  • Marshall Wace first reported a position in Kura Oncology in Q1 2018 and held it in 12 quarters.
  • Marshall Wace's Kura Oncology position peaked at $8.26M in Q4 2024.
  • 215 funds tracked by Wall St. Rank held Kura Oncology as of Q4 2025.

Based on Marshall Wace's 13F filing for Q4 2025, filed 13 Feb 2026.